[ Price : $8.95]
FDA clears an Optovue 510(k) for its Normative Database for the RTVue OCT device used as a reference tool in assessing retina nerv...[ Price : $8.95]
A New York Times article describes the debate over whether new genetically engineered cancer treatments are best evaluated through...[ Price : $8.95]
CDER deputy director for clinical science Bob Temple says during a television interview that there is nothing wrong with a drug re...[ Price : $8.95]
Information submitted to FDA in a Genentech supplemental BLA for Avastin is deemed a major amendment by FDA and therefore the revi...[ Price : $8.95]
FDA reportedly will hold a two-day public hearing on issues and challenges associated with implementing a regulatory pathway for f...[ Price : $8.95]
The Federal Trade Commission says it appears that two Rx-360 supplier audit programs have a useful purpose and will not harm compe...[ Price : $8.95]
FDA approves a Medtronic PMA for its continuous sinusoid technology Integrity Coronary Stent System.[ Price : $8.95]
FDA's Cardiovascular and Renal Drugs Advisory Committee votes unanimously to recommend approval of Boehringer Ingelheim's blood th...